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Abstract
Background:  The benefit of regular multidimensional assessment of older people remains
controversial. The majority of trials have been too small to produce adequate evidence to inform
policy. Despite the lack of a firm evidence base, UK primary care practitioners (general
practitioners) are required to offer an annual health check to patients aged 75 years and over.
Design: Cluster-randomised factorial trial in primary care comparing a package of assessments (i)
universal versus targeted assessment and (ii) management by the primary care team (PC) or a
multidisciplinary geriatric assessment team (GM). The unit of randomization is the general practice.
Methods: Older people aged 75 and over eligible for the over 75s health check and excluding
those in nursing homes or terminally ill were invited to participate. All participants receive a brief
assessment covering all areas of the over 75s check. In the universal arm all participants also receive
a detailed health and social assessment by a study nurse while in the targeted arm only participants
with a pre-determined number and range of problems at the brief assessment go on to have the
detailed assessment. The study nurse follows a standard protocol based on results and responses
in the detailed assessment to make referrals to (i) the randomised management team (PC or GM)
(ii) other medical services, health care workers or agencies (iii) emergency referrals to the GP. The
main outcomes are mortality, hospital and institutional admissions and quality of life. 106 practices
and 33,000 older people have been recruited to the trial.
Background
Indications for possible benefit from regular assessment
of elderly people came from early studies several decades
ago in the UK which found high levels of undetected
problems in elderly people [1–3] and highlighted the
need for a systematic approach to problem detection.
Around the same era, an approach emerged which em-
phasized function and disability in the medical care of
elderly people and questionnaires were developed to as-
sist in the assessment of a range of physical, mental and
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social dimensions [4]. Doubts about the feasibility of rou-
tine assessment of elderly people [5] led to the notion of
two stage targeted screening to identify those at greatest
risk or greatest need [6–8]. In the 1980s results from three
randomised controlled trials, which examined the benefit
of socio-medical assessment, were published [9–12]. Two
of these trials took place in the UK [9,10] in the setting of
general practice and one in Denmark among elderly peo-
ple living in the community [11,12]. These trials suggest-
ed some possible benefits on mortality and hospital
admissions (mainly the Danish trial) but none of the tri-
als provided convincing evidence for regular assessment
of elderly people.
Despite these equivocal results, the Department of Health
in 1990 introduced a contract of service for general practi-
tioners, which required them to offer an annual assess-
ment to patients aged 75 years, and over [13]. Although
the contract specified the broad areas for assessment (Ta-
ble 1), the method, level and nature of assessment were
not defined. Different models of initial assessment have
been used (e.g. postal, lay person and nurse) and targeted
screening has been recommended [14] but none of these
strategies have been rigorously evaluated and compared.
Models of subsequent management of problems identi-
fied through the assessment process also require evalua-
tion. In studies conducted mainly in North America,
multidisciplinary teams in the hospital setting (usually
geriatrician, nurse, therapist and social worker) appear to
offer advantages in terms of survival, functional status and
use of hospital services [15], but the costs and benefits of
the multidisciplinary team as a integrated component of
multidimensional assessment, when compared with the
usual model of primary care, have yet to be established.
The principal objective of the MRC trial of assessment and
management of older people in the community is to eval-
uate a package of multidimensional assessment and man-
agement of older people in the context of the 1990
contract of service. The two main components of the pack-
age are the method of assessment – Universal or Targeted-
and the method of clinical management – multidiscipli-
nary geriatric team (GM) or usual primary care (PC). A
secondary objective is to compare different methods of
administering a brief screening questionnaire (postal, lay
or nurse) These three methods were chosen because they
that had been advocated as part of an assessment process
(14) (with obvious differences in cost implications) but
no formal evaluation of their performance in a single trial
has been carried out. We were interested in establishing
whether response rates, levels of missing information and,
for certain health conditions, sensitivity and specificity
compared to measurements at the detailed assessment,
varied for the three methods.
Design
The study is a cluster-randomised trial with a 2 × 2 facto-
rial design i.e. practices are randomised to: Universal as-
sessment (plus randomised to GM or PC) or Targeted
(plus randomised to GM or PC) (Figure 1). In addition to
the main randomisations, practices are also randomised
to one of the three methods of administering a brief ques-
tionnaire, which are balanced across the main ran-
domised groups. All randomisation is at the level of the
general practice.
Description of procedures
All practices administer a brief assessment questionnaire
to participants in the study either by post, or by a layper-
son, or by a nurse. Following the brief assessment, practic-
es in the Universal arm carry out a detailed examination
by the study nurse in all patients (irrespective of their re-
sponses on the brief assessment) while those in the Tar-
geted arm carry out a detailed assessment only in those
patients who "trigger" on the brief assessment. The study
nurse follows a standard protocol based on results and re-
sponses in the detailed assessment to make referrals to (i)
the randomised team (PC or GM)(ii) other medical serv-
ices, health care workers or agencies (iii) emergency refer-
rals to the GP.
Methods
Methods of assessment
The brief assessment questionnaire
The brief assessment questionnaire, developed in con-
junction with Wallace and Williams (who have published
the binary response version of the questionnaire) [16]
covers all the areas specified in the GP contract: social en-
vironment, activities of daily living, sensory problems,
mobility, physical symptoms including continence, men-
tal condition, use of medication. We chose to use a graded
response scale based on the results of pilot studies com-
paring graded with binary responses, which showed that
binary responses inflated positive responses and that pa-
tients had difficulty making choices on a binary scale. The
areas and the corresponding questions and scale are
Table 1: Department of Health Contract of Service with General 
Practitioners 1990
Annual invitation to each patient aged 75 and over to participate in 
consultation
Assessment should include where appropriate
- sensory function
- mobility
- mental condition
- physical condition including continence
- use of medicines
- social environmentBMC Health Services Research 2002, 2 http://www.biomedcentral.com/1472-6963/2/21
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Figure 1
Design of MRC trial of assessment and management of older people in the community
TARGETED
N = 54 practices Lay
18 practices
Postal
18 practices
Nurse
18 practices
PC   
GM
Detailed assessment 
only if triggered
Detailed 
assessment always
PC   
GM
PC   
GM
PC   
GM
PC   
GM
PC   
GM
UNIVERSAL
N = 54 practices Lay
18 practices
Postal
18 practices
Nurse
18 practicesBMC Health Services Research 2002, 2 http://www.biomedcentral.com/1472-6963/2/21
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shown in Table 2. Additional questions on alcohol con-
sumption, cigarette smoking and physical activity have
been included for epidemiological purposes. Criteria for
triggering to the detailed assessment are 3 or more prob-
lems identified from the brief assessment or any one of 4
"serious" symptoms. According to the randomisation, pa-
tients are interviewed either by a lay person (usually a
member of the practice staff) or the study nurse or the
questionnaire is mailed. Patients are invited to attend the
surgery for the interview but are given the option of the in-
terview being carried out at home. Identical questions are
asked in each version of the questionnaire but for the
postal questionnaire the scoring of the triggers is carried
out by the study nurse. The postal questionnaire was
printed in large font to permit easy reading.
The detailed assessment
Patients are invited to attend the surgery for the detailed
assessment but are given the option of the assessment be-
ing carried out at home. The detailed assessment covers
the same areas as specified above but in greater depth for
example, whispered voice test for hearing [17], Glasgow
Acuity Cards for vision [18], Mini Mental State Examina-
tion for cognitive impairment [19], the Geriatric Depres-
sion Scale [20]. Additional questions include more
detailed assessment of symptoms (e.g. Rose chest pain
questionnaire for possible angina [21], respiratory prob-
lems, urinary and faecal incontinence, examination of legs
and feet and a modified version of a checklist for possible
drug interactions [22]. Additional biological measure-
ments include blood pressure, heart rate, and dipstick for
Table 2: The brief assessment questionnaire areas, specified in the GP contract and corresponding questions
Area Questions Response scale and trigger
Social Environment Social support
Living circumstances Carer for someone else at 
home Someone to call on for help Frequency of 
social contacts
Live alone or is carer and nobody to call on for 
help or rarely sees relatives/friends
Self care
Wash all over Unable and no help
Get dressed Unable and no help
Cut toe nails Unable and no help
Cook hot meal Unable and no help
Do light housework or simple repairs Unable and no help
Financial problems
Difficulty keeping home warm Often or always
Problems in making ends meet Always
Sensory impairment Difficulty hearing A lot
Difficulty seeing newsprint A lot
Mental condition Feeling sad, depressed or miserable Often or always
Problems with everyday memory Always
Difficulty managing finances Always
Problems remembering medication Often or always
Physical condition Vomited blood Yes1
Coughed up blood Yes1
Severe shortness of breath sitting Yes
Severe swollen legs Yes
Unexpected weight loss Yes1
Falls in last six months > 41
Incontinence Urinary Once a week or more often
Faecal Once a week or more often
Use of medicines Number of prescribed medicines > 7
Mobility Walk 50 yards Unable and no help
Go up and down stairs and steps Unable and no help
Do shopping Unable and no help
Lifestyle (not part of GP contract) Use of alcohol in previous week Current smoker 
(amount daily) Physical activity
Not included as trigger
For nurse/lay only Any other condition/problem warranting a detailed 
assessment
1 Potentially serious symptom triggering detailed assessmentBMC Health Services Research 2002, 2 http://www.biomedcentral.com/1472-6963/2/21
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blood, protein, and urine. In all patients a blood sample
is taken for a full biochemical screen. Additional laborato-
ry investigations are triggered by question responses or ab-
normal results e.g. faecal occult testing for a positive
response to a question on blood in the stools, an MSU for
a positive dipstick result for protein or blood. Patients are
also assessed for social problems such as financial difficul-
ties, social isolation. The choice of conditions to screen for
was based on a review of the available literature [23]. The
study nurse follows a protocol, based on results and re-
sponses in the detailed assessment, to make referrals to (i)
the clinical teams (PC or GM) (ii) other medical services,
health care workers or agencies (iii) emergency referrals to
the GP. Referrals to PC/GM are for serious clinical prob-
lems, such as depression, frequent falls, abnormal bio-
chemical results, severe breathlessness, and severe leg
oedema. A full list is given in Table 3. The conditions for
referral to the teams were based on the results of a survey
of 90 general practitioners from the MRC General Practice
Research Framework (MRC GPRF) and 52 geriatricians,
who had indicated an interest in taking part in the study.
Other referrals are to specialities or professions for a vari-
ety of problems, such as ophthalmology for visual impair-
ment (not due to refractive errors), audiology, continence
advisors, community psychiatric nurse, social services (Ta-
ble 4). For certain problems, patients are advised to seek a
consultation e.g. with an optician for refractive error
(VA<6/18 corrected with pinhole), or to a dentist for
problems with mastication.
Management teams
The teams follow their "usual" practice and there was no
attempt to impose a formal protocol. Information is col-
lected on investigations, diagnoses, services and treat-
ments that result from the referral and any further
referrals.
Outcome measures
The principal outcome measures for hypothesis testing are
mortality, hospital and institutional admissions and qual-
ity of life. Mortality follow-up is achieved by registering all
eligible patients with ONS for notification of death, date
and cause of death. Hospital admissions are collected for
each participant for a 2-year period from the time of the
Table 3: Criteria for referral to primary care team (PC) or geriatric evaluation and management team (GM) 1
Clinical domain Referral Criteria
Bradycardia Heart rate <50
Tachycardia Heart rate > = 110
Abnormal ECG ECG carried out for irregular pulse
Hypertension Aged less than 80 years average repeat sitting systolic
> = 180 mmHg or sitting diastolic
> = 100 mmHg. To refer for either,
standing systolic must be > = 140 mmHg
Untreated Angina Positive on Rose chest pain questionnaire
Severe leg oedema Swelling of legs up to knees on getting up in the morning
Severe shortness of breath Short of breath on talking
Weight loss Recent unexplained weight loss of more than half a stone
Depression GDS score >7 and no treatment or more than 6 months on present treatment
History of recent falls > 4 falls in previous 6 months
Infected MSU MSU tested when patient reports urinary incontinence or has proteinuria or haematuria on dipstix
Other urinary problems (men) Difficulty in micturition Nocturia more than twice nightly
Faecal incontinence Soiling 3 or more times a week
Faecal occult blood Blood in motions and stool specimen is positive for blood
Change in bowel habits Constipation Diarrhoea
Haematemesis Recent history of vomiting blood
Haemoptysis Recent history of coughing up blood
Dysphagia Difficulties swallowing
Glycosuria Positive for glucose on dipstix
Abnormal biochemistry Outside normal ranges for haemoglobin, white cell count, platelets, TSH, glucose, sodium, potassium, 
urea, creatinine, albumin, calcium, bilirubin, alkaline phosphatase, aspartase-transaminase
Potential drug interactions Modified version of the Stockley checklist
Any other serious condition warranting 
further investigation
Nurse judgement
1 Excludes details on criteria for emergency referralsBMC Health Services Research 2002, 2 http://www.biomedcentral.com/1472-6963/2/21
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brief assessment using information from hospital dis-
charge letters in the patients' GP records. Information col-
lected includes specialty, dates of admission and
discharge, diagnoses, specialty of consultant. The dis-
charge letter is considered to be a reliable source since this
is the routine method of providing information to general
practitioners from hospital services. Institutional admis-
sions are collected on an ongoing basis for each patient
from the date of the baseline assessment. Quality of Life
interviews are carried out in the patient's own homes by
fieldworkers who are independent of the practice. The in-
terviews take place (i) at baseline and prior to the assess-
ment (ii) 18 months following the baseline interview (iii)
36 months following the baseline. The Quality of Life core
interview schedule includes four dimensions from the
Sickness Impact Profile (SIP) (mobility, self-care, home-
management, social interaction) [24], and the Philadel-
phia Geriatric Morale Scale (PGMS), [25], a 17-item meas-
ure of morale specifically developed for use with older
people.
We used slightly different follow-up periods for outcome
collection since we would expect any effect on hospital ad-
missions to be seen at an earlier rather than later stage
whereas mortality effect might show some lag. Quality of
life is measured both at 18 months and at 3 years, which
covers the same period as both the hospital admissions
and the mortality.
Use of services
Information on use of services is being collected for the
economic analysis. Use of public sector services (health
and social services) is collected through two sources (i) in
the quality of life questionnaire at baseline, 18 and 36
months) (ii) through a postal questionnaire mailed to
randomly selected cross sectional samples of patients at 6
monthly intervals across the follow-up period. This per-
mits us to have information both from a longitudinal
sample over the 3 years of the trial from participants in the
quality of life sample while the cross sectional random
sample provides a more representative sample across the
follow-up period since it includes those those who may
die or leave the practice.
Trial hypotheses and sample size
Sample size methods
Sample size calculations for mortality and hospital admis-
sions were calculated from a program provided by Martin
Shipley at University College London, Department of Ep-
idemiology, using methods for cluster randomisation de-
scribed in Shipley et al [25] and under the assumption
that the rates follow a Poisson distribution. The program
uses the formula
where study power is given by 1-β, Cβ is the critical value
of the normal distribution in the upper tail of the standard
normal curve, Cα/2 is the critical value of the normal dis-
tribution for a two sided value of alpha (in our case taken
to be alpha = 0.01), λ is the average value of the underly-
ing event rate, ∆ is the difference to be detected between
the event rate in the main randomised groups of the trial
(universal minus targeted or GM minus PC), 2 σ2(1-κ) is
the variance of the underlying event rates, nH is the har-
Table 4: Detailed assessment: referrals to other health professionals/agencies
Referral to Problem Referral criteria
Audiology Hearing impairment Fail whispered voice test and no wax
Ophthalmologist Vision impairment VA <6/18 in either eye not corrected by pinhole
Memory Clinic /CPN Moderate to severe cognitive impairment Mini Mental state < 17 or < 12 if language section could not be 
completed
Continence advisor/community nurse Urinary incontinence more than once a week and MSU not infected.
Community nurse Leg/foot ulcers/ bed sores Present on nurse examination
Chiropodist Foot problems Corns, bunions, ingrowing or long toe nails or other treatable 
foot problem on examination
Social services Self-care No help available for difficulties with dressing, cooking hot 
meal, carrying out light housework, washing and shopping
Social isolation Lack of close confident or someone to call on for help
Financial problems Difficulty in making end meet Difficulty in paying bills
Housing problems Difficulty in keeping home warm No indoor toilet
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monic mean of all 2 m sample sizes and 2 m is the
number of clusters. We took the conservative assumption
that the level of matching of the practices would be mini-
mal or essentially zero although we did attempt to bal-
ance the practices by Jarman score and SMR by stratified
randomization across the joint tertiles of SMR and Jar-
man. Expected mortality rates were based on ONS statis-
tics for England and Wales [26] with an adjustment
downwards of 0.7 of the background mortality rate on the
basis that the trial population would have lower rates
(healthy participant effect). Rates of hospital admission
[27] were adjusted down on the basis of an expected
"healthy" participant effect and additionally on the basis
that hospital admissions might be under reported and
that annual rates do not distinguish between persons and
admissions. For hospital admission rates we therefore as-
sumed that the rates might be a half of those published.
Thus in both calculations we used conservative estimates
of the rates. Sample sizes for institutional admissions
could not be calculated as there are no national data on
rates of institutional admission. The sample size calcula-
tions assumed an average of 500 eligible patients per clus-
ter followed for an average of 3 years.
Sample size estimates for the quality of life measures used
the formula given by Hsieh [28] based on the Z approxi-
mation,
N = 8(Sb
2 + Sw
2/m) (zα/2 + zβ)2/d2
where N is the total number of clusters, Sb
2 is the between
cluster component of variance, Sw
2 is the within cluster
component of variance, m is the number of individuals
within each cluster, and zα/2 and zβ/2 are the critical
points of the normal distribution for alpha of 0.01 and 1-
β of 0.9 and d is the difference between randomised
groups in the means of qol scores. Estimates of Sw
2 and d2
were based on SIP scores from pilot studies of 52 older
people attending geriatric out patient clinics and POMS
scores from 115 patients on the care of the elderly wards
at the Hammersmith Hospital. We expected 75% of base-
line responders to provide quality of life data at the 3 year
end point (m = 350). Since no data were available for Sb
2
(which is expected to be considerably smaller than Sw
2)
we used varying estimates of the intraclass correlation co-
efficient (Sb
2/ Sb
2 + Sw
2) (0.01, 0.02, 0.04).
Estimates of sample size
108 practices (with an average of 500 patients aged 75
years and over) are required to detect differences between
Stage 1 assessment methods (targeted versus universal) of:
at least 15% in mortality assuming a background mortal-
ity rate of approximately 60/1000 person years over an av-
erage follow up period of 3 years; at least 10% in 2 year
hospital admissions assuming a background first admis-
sion rate of 150/1000 person years. This sample size is suf-
ficient to detect differences between the two management
strategies (GM and PC) of at least 22% in mortality and at
least 15% in hospital admissions. Smaller numbers of
practices are required to detect differences in quality of
life. A random sample of 24 practices is adequate to detect
differences between Stage 1 assessment methods of at
least 15% in PGMS and SIP and between GM and PC of at
least 25% in PGMS and SIP. The size of the effects to be
tested were based on previous trials and a realistic expec-
tation of what might be achievable and of public health
importance.
Trial population
The trial is being conducted in practices recruited through
the MRC GP Research Framework with list sizes of be-
tween 200 and 700 patients aged 75 years and over and se-
lected to be representative of the joint tertiles of Jarman
and Standard Mortality Ratios (SMRs) in UK practices. To
be eligible for randomisation in the trial, recruited practic-
es first had to obtain the agreement of the local geriatri-
cian to participate (in order to ensure no selection bias of
geriatricians in practices subsequently randomised to GM
or PC). Eligible patients were aged 75 years and over in the
year the practice undertook the assessments, excluding an-
yone in long-term care or with terminal illness. Patients in
residential or sheltered accommodation were included.
Method of allocation to groups
Allocation to groups was by a computer generated ran-
domisation list, stratified by Jarman and SMR tertile as
practices were recruited to the trial.
Informed consent
The over 75s check is a contractual obligation of general
practitioners. The letter of invitation to the study was
done in the context of the letter of invitation to the annual
check. The letter of invitation informed patients that the
check could be done as part of a research study with a brief
description of the intervention (this varied according to
the practice randomisation). Patients were given the op-
portunity to have the check carried out in the usual way
and reassured that non-participation in the study would
not affect their usual care.
Ethical approval
Local Research Ethics Committee approvals were ob-
tained for all the practices participating in the trial.
Analysis
The principal analysis is of the components of the package
of interventions and therefore all analyses will take ac-
count of the other main randomisation. The results will be
presented for (i) universal versus targettted (ii) GM versus
PC. In order to ensure that the method of administeringBMC Health Services Research 2002, 2 http://www.biomedcentral.com/1472-6963/2/21
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the brief questionnaire does not influence the main ran-
domisations, the analyses will also be adjusted for the
'nurse vs. lay vs. postal' randomised intervention. The pri-
mary population for analysis is the "Intention to Treat"
population (i.e. all those eligible for the trial and invited
to take part irrespective of participation). Pre-specified co-
variates are age, sex and (at practice level) SMR and Jar-
man score. There will be no sub-group analyses in the
primary analysis. All analyses will take account of cluster
randomisation which has the effect of increasing the
standard errors of the estimates and therefore it is unlikely
that spurious significant effects will be detected. Second-
ary analyses will be conducted as above on the "per proto-
col population"
Economic analysis
The primary objective of the economic analysis is to deter-
mine the relative costs and costs per life year gained of the
different components of the assessment and management
packages. Cost analysis will compare the direct health and
social care costs of assessments and the longer term costs
of care and treatment following the interventions (use of
services, hospital admissions, and instiututional admis-
sions). Service use data over the follow-up period of the
trial will be obtained from longitudinal samples (as part
of the quality of life questionnaire) and from the repeated
cross sectional samples.
Progress on trial
109 practices were randomised and study staff trained in
the study protocol; three practices withdrew before carry-
ing out any of the study interventions (one of these was
also randomised to the quality of life collection). It was
too late to replace these practices so the final achieved tar-
get is 3 practices short. 106 practices and 33,000 patients
are participating in the trial. The practices are equally dis-
tributed over the Universal (n = 53) or Targeted (n = 53)
arms and of the PC (n = 53) or GM (n = 53) arms of the
trial.
Discussion
This trial is, by far, the largest and most comprehensive
study internationally to examine the benefits of multidi-
mensional assessment of older people in the community.
Although a number of trials have been published since the
introduction of the 1990 contract, including three from
the UK, they have, in common with previous trials, been
too small to produce results of sufficient precision and
certainty to inform policy decisions [29]. Studies conduct-
ed in the US are difficult to translate to the UK health care
setting. Previous trials have also suffered from a number
of other methodological problems: individual patient
randomisation in the same healthcare setting (e.g. general
practice) which may lead to contamination of ran-
domised groups and dilution of effect; lack of a clearly de-
fined protocol for intervention and referral; and (in the
US studies) low participation rates and over-representa-
tion of fit older people. One systematic review and three
meta analyses of these trials have been published [30–33],
but have come to different conclusions concerning bene-
fits on major outcomes, such as mortality and hospital ad-
missions. Our trial avoids some of these design problems
by employing: randomisation at the general practice level,
which reduces the possibility of contamination; clearly
defined protocols for the intervention and referrals; mini-
mal exclusion criteria (terminally ill or in institutional
care); high power to test hypotheses on major outcomes.
These outcomes were chosen because a number of trials
had suggested possible benefits on mortality, institutional
(or nursing home) and hospital admissions. Individual
studies and meta analyses have also looked at outcomes
such as functional decline or physical morbidity – we used
comparable domains of health related quality of life as an
outome to capture these aspects and also included morale
and social interaction as other relevant outcomes. Our tri-
al compares different strategies of multidimensional geri-
atric assessment. These different levels are analogous to
the different intensities of screening described by Stuck
and colleagues in their recent meta analysis (33), for ex-
ample universal assessment with management by a spe-
cialist geriatric team in our trial is comparable to their
category of "multidimensional geriatric assessment and
follow-up" in the meta-analysis. Hence our results are ap-
plicable across differing health care contexts. Our trial in-
terventions and referrals across a broad range of health
care professionals and other agencies address disability
and impairment as well as disease which we consider to
be an appropriate balance rather than adopting either a
purely medical or functional model of health at older ag-
es.
There are a number of limitations of our trial. Cluster ran-
domisation trials require substantially greater numbers
than trials of individual randomisation, and are more sus-
ceptible to practice effects e.g. loss of all patients to fol-
low-up if a practice withdraws. The large numbers also
made certain aspects of data collection prohibitively ex-
pensive. For this reason we have not collected any detailed
information on services and treatments already being re-
ceived by trial participants ie prior to the trial interven-
tions, although we will have some limited information on
these if part of the criteria for referral. Also, funding did
not permit collection on hospital admissions over a long-
er period. Nor were we able, for costs reasons, to repeat
the intervention packages over several years or, to exam-
ine the benefits of annual assessment versus some other
time period such a triennial assessment. A further limita-
tion of our trial design was that it was not possible to have
a control group (i.e. a group randomised to no interven-
tion) because of the contractual obligation of generalBMC Health Services Research 2002, 2 http://www.biomedcentral.com/1472-6963/2/21
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practitioners to offer an annual health check to the over
75s. It is extremely unfortunate that this policy was intro-
duced (despite the lack of a firm evidence base) because it
has meant that a properly controlled study cannot be con-
ducted in the UK.
As with other trials, especially in health services research,
there are issues of generalisability of the results to other
relevant health care professionals (practice nurses, general
practitioners and geriatricians) and to patients. The prac-
tices in the trial belong to the MRC General Practice Re-
search Framework and, although the patients in those
practices were representative of the wider patient popula-
tion (in terms of deprivation and mortality), the general
practitioners have a interest in being involved in research.
However we have no reason to believe that the general
practitioners or the nurses had any particular expertise in
geriatric assessment or management. The geriatricians
were recruited to the study by virtue of being the linked lo-
cal geriatric service to the general practice and were not se-
lected for any particular expertise or experience in
research. Ensuring agreement of the local geriatricians to
take part in principal, which was a criterion for randomi-
sation of the practice (i.e. before knowledge of whether
the practice was randomised to PC or GM), reduced the
likelihood of selection bias of geriatricians. Nonetheless it
will be important to describe the clinical management
through the collection of process information so that, if
the trial shows a benefit for a particular package of assess-
ment and management, its components can be described.
The trial results are also of direct relevance to the "single
assessment " recommended by the National Service
Frameworks for Older people [34], in particular the deci-
sion on how and to whom the brief overview assessment
should be targeted. The levels of benefit to be tested in the
trial, if demonstrated, will result in important reductions
in mortality, hospital and institutional admissions and
improved quality of life. These results will be relevant, not
only to the UK older population but also to many other
countries and settings where health care of older people
has become a policy priority.
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